AFP and metabolic dysfunction-associated steatohepatitis: In patients with nonalcoholic steatohepatitis, the GALAD score, which determines the risk of HCC based on a patient’s sex, age, and serum levels of AFP, AFP-L3, and PIVKA-II, identified patients with any-stage HCC with an area under the curve (AUC) of 0.96 [9].